newsfilter
← Latest News
Business Wire·

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023

Full Year 2023 vs. Full Year 2022: Record Net Revenues: $125.8 million, a 14% increase Patient Services Revenue: $76.5 million - Device Solutions Revenue: $49.2 million, increases of 11% and 20% Adjusted EBITDA